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Abstract. The discriminative stimulus effects of several 
g-opioid agonists were examined under conditions of 
opioid sensitization or tolerance, i.e., before and after 1- 
week SC infusions of naloxone or g-opioid agonists. Rats 
were trained to discriminate 3.0 mg/kg morphine from 
saline using a two-lever, discrete trial, shock-avoidance/ 
escape procedure. The rats generalized completely to 
morphine, fentanyl, meperidine, buprenorphine, and 
etorphine, and partially to pentazocine. A 7-day infusion 
of naloxone (0.3 mg/kg per h) potentiated the discrimina- 
tive stimulus effects of all of these drugs. The magnitude 
of the increased potency varied indirectly with the effica- 
cy of the kt-opioid agonists; potency ratios (we-infusion 
EDs0/post-infusion EDs0 ) ranged from 1.58 (etorphine) to 
3.58 (pentazocine). Stimulus generalization to morphine, 
fentanyl, and meperidine also was examined following 
infusions of equieffective doses of each of these three 
drugs. Differences among drugs were generally small, and 
failed to reach statistical significance. Nonetheless, the 
induction of ~t-opioid tolerance did seem to vary with the 
efficacy of the three g-opioid agonists. Thus, meperidine 
(6.25 mg/kg per h), which has the lowest efficacy of the 
drugs infused, produced the greatest shift to the right of 
the stimulus-generalization curves of these three drugs; 
the post-meperidine PR ranged between 0.40 and 0.61. 
Fentanyl (0.1 mg/kg per h), a drug with a higher efficacy 
at g-opioid receptors, did not produce tolerance to the 
discriminative stimulus effects of morphine, fentanyl, or 
meperidine; potency ratios ranged from 0.50 to 0.75. Po- 
tency ratios for buprenorphine, etorphine, fentanyl, 
meperidine, and morphine after 7-day morphine infu- 
sions (0.75 mg/kg per h) ranged from 0.38 (buprenor- 
phine) to 0.80 (etorphine). Morphine induced significant 
tolerance only to the discriminative stimulus effects of 
fentanyl. Our results suggest that different cellular mech- 
anisms underlie the development of tolerance and sensi- 
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Continuous exposure to opioid antagonists such as 
naloxone or naltrexone, increases the number of opioid 
binding sites in the central nervous system. The increase 
in g-opioid receptors is accompanied by an increase in 
the potency of morphine to produce electrophysiological 
and neurochemical effects (Bardo et al. 1983; Ahtee et at. 
1990), as well as analgesic effects (Tang and Collins 1978; 
Yoburn and Inturrisi 1988; Paronis and Holtzman 1991). 
However, studies on the potency of g-opioid agonists as 
discriminative stimuli following naltrexone infusions 
have produced mixed results. A 7-day infusion of 6 mg/ 
kg per day naltrexone did not change the discriminative 
stimulus effects of fentanyl in rats (Ayesta et al. 1992). 
However, the potency of morphine increased by two-fold 
for both stimulus control of behavior and suppression of 
food-reinforced responding following 8-day infusions of 
18 mg/kg per day naltrexone (Young et al. 1991a). To 
date, the effects of continuous naloxone infusions on the 
discriminative stimulus effects of other g-opioid agonists 
have not been assessed. 
In contrast, numerous studies have focused on the de- 
velopment of tolerance to the discriminative stimulus ef- 
fects of ~t-opioid agonists. Early reports suggested that 
tolerance did not develop (Colpaert et al. 1976, 1978). 
Since then, however, it has become apparent that toler- 
ance to the discriminative stimulus effects of g-opioid 
agonists will develop if the discrimination training is in- 
terrupted for the duration of the supplemental adminis- 
tration of the tolerance-inducing drug (Miksic and Lal 
1977; Young et al. 1991b). 
In the current experiments, we examined whether the 
morphine-like discriminative stimulus effects of g-opioid 
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agonists  demons t ra te  different degrees of sensi t izat ion 
and  tolerance following con t inuous  infusions of either 
na loxone  or g-opioid  agonists.  Fur thermore ,  we investi- 
gated the abilities of three drugs with vary ing  degrees of 
efficacy at the g-opioid  receptor  to induce  tolerance to 
morphine- l ike  discr iminat ive  s t imulus  effects. M o r p h i n e  
was used as the proto typica l  g-opioid  agonist ,  fentanyl  as 
a g-opio id  agonis t  with a higher efficacy t h a n  morphine ,  
and  meper id ine  as a g-opioid  agonis t  with a lower effica- 
cy. The  discr iminat ive  s t imulus  effects of morphine ,  
meperidine,  and  fentanyl  were examined  before a n d  after 
1-week infusions of either na loxone  or one of the three 
agonis t  drugs. Thus,  the s t imulus  genera l iza t ion  of mor-  
phine,  meperidine,  and  fentanyl  were examined  under  
four different t r ea tment  condi t ions ,  so that  relative sensi- 
t izat ion could  be compared  to relative tolerance,  as a 
funct ion  of agonis t  efficacy. The role of efficacy in the 
abil i ty of a drug to produce  morphine- l ike  discr iminat ive  
s t imulus  effects fol lowing con t inuous  drug t r ea tment  was 
also examined.  The discr iminat ive s t imulus  effects of the 
mixed agonis t / an tagonis t s  pentazocine  and  bup r e no r -  
phine, and  the potent ,  full g-opioid  agonis t  e torphine  
were de te rmined  in rats that  had received naloxone,  and  
the s t imulus  general iza t ion of b u p r e n o r p h i n e  and  etor- 
phine  was also examined  following morph ine  infusions. 
Materials and methods 
Subjects. Male Sprague-Dawley rats (Charles River, Inc., Raleigh, 
N.C.) weighing 150-300 g were used. Subjects were experimentally 
and drug naive at the start of the experiment. Rats were initially 
housed in groups of three, in standard laboratory cages. Occasion- 
ally, cagemates would attack each other; this was independent of 
drug treatment. When this behavior persisted, subjects were sepa- 
rated and housed individually for the remainder of the study. All 
animals were kept in a temperature-controlled colony room with a 
12-h tight/dark cycle (lights on at 7:00 a.m.). Food (Purina Rodent 
Chow; Purina Mills, St. Louis, Mo.) and water were available ad 
libitum. 
Drug discrimination training. Rats were trained to discriminate be- 
tween 3.0 mg/kg morphine and saline in a two-choice discrete-trial 
avoidance/escape paradigm. Morphine or saline was injected SC 
30 min before the start of a training session. Sessions were conduct- 
ed in an operant chamber equipped with three levers, an "observ- 
ing" lever mounted on one wall, and two "choice" levers, separated 
by a Plexiglas partition, mounted on the opposite wall. The begin- 
ning of a trial was signalled by the illumination of the house light 
and onset of white noise. Beginning 5.0 s after the onset of the trial, 
a constant current shock generator delivered a brief electrical stim- 
ulus (1.0-1.5 mA) to the grid floor of the chamber every 3.0 s in 0.5-s 
pulses. The rat was required to press the observing lever, then turn 
and press one of the two choice levers. The observing response 
terminated the white noise and the appropriate choice response 
extinguished the light, terminated the electrical stimulus, and ended 
the trial. Completion of the two-response chain within the first 5.0 s 
of the trial avoided delivery of the electrical stimulus. Pressing the 
incorrect choice lever reactivated the white noise and required that 
the observing lever be pressed again before a correct choice could be 
made. For half of the animals the right lever was designated as the 
saline lever, and the left lever was the morphine lever; lever assign- 
ments were reversed for the remaining rats. Each trial lasted a 
maximum of 65 s, and was followed by a 50-s time-out, during 
which the chamber was dark. Experimental sessions consisted of 21 
trials or 30 min, whichever occurred first. Generally each rat com- 
pleted one session per day except on test days, and training sessions 
were conducted 5-7 days/week. A microcomputer controlled sched- 
ule contingencies and also collected session data. The first trial of 
each session was considered a "warm up", and data from these trials 
were not collected. 
Drug discrimination testing. Stimulus generalization testing began 
after the rat reliably completed 90% of the trials on the appropriate 
choice lever for four consecutive training sessions. Criteria for main- 
taining discrimination was 90% accuracy over the four consecutive 
sessions immediately preceding a test day. During test sessions both 
levers were activated so that a response on either lever terminated 
the triM. Animals received saline before the first session of each test 
day, and then a cumulative dosing procedures was used to deter- 
mine drug effects. After the first session the subject was injected with 
a low dose of the test drug; 15 or 20 rain later the animal was 
retested, and immediately after the session was injected with the 
next dose of drug. The cumulative dose was increased by 0.25 or 0.5 
log units. For example, if the animal initially received 0.1 mg/kg, the 
second injection would be at a dose of 0.20 mg/kg, for a cumulative 
dose of 0.30 mg/kg. This procedure continued until complete stimu- 
lus generalization occurred, or for a maximum of five sessions. 
Some session parameters were altered on test days: the time-out 
period was shortened to 30 s and the maximum session length and 
pretreatment time were both decreased to 20 min. On days when 
fentanyl or etorphine were tested, the pretreatment time was short- 
ened further to 15 min. A minimum of 6 days intervened between 
initial generalization tests, and a recovery period of at least 3 weeks, 
during which training sessions were conducted, followed each 7-day 
drug infusion. If an animal failed to maintain criterion performance 
at any point in the study, testing of that animal was temporarily 
suspended and training continued until criterion performance re- 
sumed. 
Experimental design. Rats that attained criterion performance, 90% 
condition-appropriate responding over four consecutive (daily) ses- 
sions, were tested with four "'cumulative" saline injections, using the 
test contingencies described above, followed by a test session with 
the training dose of morphine, to check for any nonspecific effects of 
completing five sessions in 1 day. Subsequently, stimulus-general- 
ization curves for morphine, fentanyl, and meperidine were com- 
pleted in each rat that successfully discriminated the morphine 
training dose after the four cumulative saline sessions. The cumula- 
tive dosing procedure allowed individual dose-response curves to 
be completed for each animal in a single day. Phencyclidine (PCP), 
a non-opioid psychoactive drug, was tested as a control for the 
specificity of stimulus generalization. 
The tests of morphine, fentanyl, and meperidine were conducted 
in a randomized fashion across subjects. Following these initial 
generalization tests, the subjects were retested with morphine. 
Twenty-four hours later the rats were implanted for 1 week with 
sham osmotic pumps, i.e., empty pumps that had been used previ- 
ously. Training sessions were suspended during these 7 days. Twen- 
ty-four hours after removal of the pumps, the morphine stimulus- 
generalization curve was redetermined in each rat. Subjects that 
showed an effect of the sham pump, that is, the dose-response curve 
for stimulus generalization after removal of the pump was shifted 
more than 1/4 log unit from the previous determination, were ex- 
cluded from further study. 
The general testing procedure, following the initial tests de- 
scribed above, was as follows: the morphine-like discriminative 
stimulus effects of a test drug were determined using the cumulative 
dosing procedure. An osmotic pump was implanted the next day, 
releasing naloxone (0.3 mg/kg per h), morphine (0.75 mg/kg per h), 
fentanyl (0.01 mg/kg per h), or meperidine (6.25 mg/kg per h). The 
infused dose of naloxone was chosen based on the results of an 
earlier study (Paronis and Itoltzman 1991), which showed that a 
1-week infusion of 0.3 mg/kg per h naloxone increased the analgesic 
potency of several g-opioid agonists. The infused doses of agonists 
also were used in an earlier study (Paronis and Holtzman 1992). 
These doses of morphine, fentanyl, and meperidine were equated on 
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the basis of their acute analgesic potency, i.e., for each drug, the dose 
delivered hourly represents one quarter of the acute analgesic EDso 
of the drug. At these doses, each of the three infused drugs produced 
some degree of cross-tolerance to the analgesic effects of g-opioid 
agonists. After 7 days, the osmotic pump was removed and the 
stimulus-generalization curve of the test drug was redetermined 24 
h later. The rat was then retrained for 3 weeks and the testing 
procedure was repeated for another drug. Challenge drugs and in- 
fused drugs were assigned in a random order; each rat was tested 
with a specific combination of test drug/infused drug only once. At 
least five rats were tested with each combination of test drug/in- 
fused drug. 
Surgery. Osmotic pumps (2ML1; Alza Corp., Palo Alto, Calif.) were 
filled with naloxone, morphine, fentanyl, or meperidine solutions at 
concentrations of 17.5~2.1 mg/ml, 44.6-57.3 mg/ml, 0.58-0.69 rag/ 
ml, or 357.4-421.3 rag/rot, respectively, depending on the weight of 
the animals, and the infusion rate of the pump. The final doses of the 
infusions were: naloxone, 0.3 mg/kg per h; morphine, 0.75 mg/kg 
per h; fentanyl, 0.01 mg/kg per h; meperidine, 6.25 mg/kg per h. 
Pumps were implanted SC through an incision in the mid-scapular 
region of the back while the rat was under light halothane anesthe- 
sia (Halocarbon Laboratories, North Augusta, S.C.). The incision 
was closed with surgical wound clips. One week later the pumps 
were removed through this incision, using the same procedure. 
Data analysis. Data were analyzed according to the number of drug 
lever responses. Individual EDsos (the log dose needed to produce 
ten drug lever responses) were calculated by linear regression of the 
stimulus-generalization curves. Subjects for which an EDso could 
not be determined, i.e., animals that emitted fewer than ten respons- 
es on the drug lever, had an EDso set at the dose of the drug 0.254).5 
log unit higher than the last dose tested, depending upon the pro- 
gression of doses used. Potency ratios (PR) were determined by 
dividing the pre-infusion EDso of a rat by its post-infusion EDso. 
The individual EDso and PR based upon the logarithmw of the 
dose, were averaged to determine group means and 95% confidence 
limits (CL). Potency ratios greater than 1.0 indicated increased po- 
tency, PR; less than 1.0 reflected decreased potency. Paired t-tests of 
the EDsos were used to determine levels of statistical significance. 
Individual PR, following naloxone infusion, were compared using a 
one-way analysis of variance; a two-way analysis of variance (in- 
fused drug versus test drug) was used to compare PR following 
agonist infusions. 
Drugs. The following drugs were dissolved in normal (0.9%) saline: 
naloxone hydrochloride, (Sigma, St. Louis, Mo.), morphine sulfate 
and meperidine hydrochloride (Penick Corp., Newark, N.J.), fen- 
tanyl citrate (McNeil Laboratories, Fort Washington, Pa.), etor- 
phine hydrochloride, buprenorphine hydrochloride, and phency- 
clidine hydrochloride (National Institute on Drug Abuse, Rockville, 
Md.). Pentazocine hydrochloride (Sigma, St. Louis, Mo.) was dis- 
solved in distilled water. All doses are expressed as the free base, 
and were injected SC in a volume of 1.0 ml/kg. 
R e s u l t s  
Stimulus generalization of /~-opioid agonists 
in rats trained to discriminate morphine 
Twenty -one  ra ts  me t  the  cr i ter ia  for d i sc r imina t ing  
3.0 m g / k g  m o r p h i n e  f rom sal ine;  three  of  these ra ts  were 
subsequen t ly  exc luded  f rom the s tudy,  as d iscussed be- 
low, and  thei r  d a t a  are  no t  inc luded  in any  g r o u p e d  data .  
The  mean  n u m b e r  of  sessions to c r i te r ion  was 67 4- 3 
( range:  50-80 sessions). Cumula t i ve  inject ions of  saline 
d id  no t  affect the  ab i l i ty  of  the ra ts  to d i sc r imina te  the 
t ra in ing  dose (3.0 mg/kg)  of morph ine .  Al l  of  the rats  
used in this s tudy  d e m o n s t r a t e d  a dose -dependen t  gener-  
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Fig. 1. Cumulative doses of mm~hine (A), fentanyl (B) and mepe- 
ridine (C) all engendered morphine-appropriate responding in rats 
trained to discriminate 3.0 mg/kg morphine from saline. The two 
highest doses of meperidine decreased responding in two animals, 
i.e., these animals completed fewer than the maximum 20 trials of 
the session. Cumulative doses of phencyclidine (PCP) did not pro- 
duce morphine-appropriate responding (D). The highest dose of 
PCP (1.78 mg/kg) reduced responding in five animals. A saline ses- 
sion always preceded the lowest dose of the drug tested; these data 
are presented in each panel to the left of the graph. Numbers indi- 
cate the mean EDso values (with 95% CL) for stimulus generaliza- 
tion. Abscissa: cumulative drug dose in milligrams per kilogram. 
Ordinates: mean number of trials terminated by a response on the 
morphine-appropriate choice lever. Upper and lower dashed lines 
indicate the criterion levels of responding for morphine and saline, 
respectively. Each point represents the mean number of trials com- 
pleted on the morphine lever, based on a single observation in 18 
animals 
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Fig. 2. In 18 of 21 animals, the dose-response curve of morphine was 
unaffected by 7-day implantation of a sham pump, and consequent 
interruption of training. Dose-response curves were determined 
twice in each animal, 24 h before implanting the sham pumps (open 
circles) and 24 h after removing the pumps (closed circles) Abscissa: 
cumulative morphine dose in mg/kg. Ordinates: mean number of 
trials terminated by a response on the morphine-appropriate choice 
lever. Each point represents the mean number of trials completed 
on the morphine lever, based on observations in 18 animals. Other 
details as in Fig. 1 
a l iza t ion  to morph ine ,  fentanyl ,  a n d  meper id ine  f rom the 
m o r p h i n e  cue. The  m e a n  EDs0s of  the p - o p i o i d  agonis ts  
for morph ine - l i ke  d i sc r imina t ive  effects are  shown in 
Fig. I (A C). Phencycl id ine  (PCP), which was tes ted as a 
n o n - o p i o i d  control ,  was no t  genera l ized  f rom the mor -  
phine  cue when tes ted up to a dose  of 1 .78mg/kg  
(Fig. 1D). A t  this dose  of P C P  five rats  d id  no t  comple t e  
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all of the trials of the session, hence higher doses of PCP 
were not  tested. 
Three rats had an enhanced response to the discrimi- 
native stimulus effects of morphine following the implan- 
tat ion and subsequent removal  of a sham pump;  these 
rats were excluded from further study. Interrupt ion of 
training for 1 week, and implantat ion of a sham p u m p  
did not affect the ability of the remaining 18 rats to dis- 
criminate morphine (Fig. 2). 
Effects of  continuous naloxone infusion on the 
discriminative stimulus effects of  l~-opioid agonists 
In the groups of animals tested with morphine (n = 5) 
and fentanyl (n = 6), the EDs0s for stimulus generaliza- 
tion before the naloxone infusion, 1.05 and 0.013 mg/kg, 
respectively, were similar to the baseline EDs0s for the 
stimulus generalization of these drugs calculated for all 
18 rats (see Fig. 1). The mean prenaloxone EDso for stim- 
ulus generalization in the rats tested with meperidine 
(n = 6) was outside the upper  95% CL of the baseline 
EDso of meperidine for the whole group of 18 rats; how- 
ever, this was due primarily to one rat that had a pre- 
naloxone EDso of 43.5 mg/kg. 
The stimulus-generalization curves for g-opioid ago- 
nists before and after the naloxone infusions are shown in 
Fig. 3; the EDso values and potency ratios are listed in 
Table 1. A 1-week infusion of 0.3 mg/kg per h naloxone 
shifted to the left the dose-response curves for all of the 
drugs tested. Following continuous administrat ion of 
naloxone, the mean potency ratios of both morphine and 
fentanyl were close to 2.0. The potency of morphine as a 
discriminative stimulus increased in each of the five rats 
tested with morphine,  potency ratios ranging from 1.12 
to 3.07. Five of the six rats tested with fentanyl showed an 
increased sensitivity to the discriminative stimulus effects 
of fentanyl. Potency ratios for fentanyl in these five rats 
ranged from 1.60 to 3.12. One rat tested with fentanyl 
before and after a naloxone infusion showed a decreased 
response to fentanyl (PR = 0.80). Meperidine, a g-opioid 
agonist with a lower efficacy than morphine,  had a mean 
potency ratio of 2.7 after the continuous naloxone infu- 
sion; the potency of meperidine increased in each of the 
six rats tested. 
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Fig. 3. Stimulus generalization of morphine 
(n = 5), fentanyl (n = 6), meperidine (n = 6), 
etorphine (n = 5), buprenorphine (n = 5), and 
pentazocine (n = 5) in rats continuously treated 
with naloxone. Dose-response curves were gen- 
erated twice in each animal, before (open circles) 
and after (closed circles) a 7-day infusion of 
0.3 mg/kg per h naloxone. Abscissa: cumulative 
drug dose in mg/kg. Ordinates: mean number of 
trials terminated by a response on the mor- 
phine-appropriate choice lever. Each point rep- 
resents the mean of five to six animals. Other 
details as in Fig. 1 
Table 1. Mean EDso (mg/kg) with 95 % 
confidence limits (n = 5-6) for the dis- 
criminative stimulus effects of ~t-opioid 
agonists before and after a %day in- 
fusion of 0.3 mg/kg per h naloxone 
Test drug Prenaloxone Postnaloxone Potency P value c 
EDso EDso a ratio u 
Buprenorphine 0.010 0.0004 2.34 0.032 
(0.006, 0.017) (0.002, 0.004) (1.13, 5.06) 
Etorphine 0.0005 0.0003 1.58 0.044 
(0.0003, 0.00007) (0.0002, 0.0004) (1.02, 2.47) 
Fentanyl 0.013 0.007 1.82 0.032 
(0.006, 0.026) (0.005, 0.010) (1.09, 3.04) 
Meperidine 16.7 6.1 2.74 0.006 
(7.2, 38.7) (3.3, 11.1) (1.55, 4.86) 
Morphine 1.05 0.56 1.88 0.027 
(0.44, 2.54) (0.18, 1.73) (1.15, 3.06) 
Pentazocine 5.92 d 1.65 3.58 0.0002 
(1.79, 19.6) (0.59, 4.62) (2.69, 4.76) 
Determined 24 h after removal of pump 
b Calculated by dividing prenaloxone EDso by postnaloxone EDso for each subject, then 
determining the group mean 
For pre- versus postnaloxone EDso 
d Includes value estimated for one rat that completed fewer than 10 trials on the 
drug lever (see Methods) 
The potency of etorphine as a discriminative stimutus 
increased after the naloxone infusion in four of the five 
rats tested and was unchanged in one. The same occurred 
with buprenorphine. Effects of the naloxone infusion on 
the discriminative stimulus effects of pentazocine were 
particularly marked. The potency of pentazocine as a 
discriminative stimulus was increased in all rats tested: 
potency ratios in individual rats were all greater than 2.5, 
ranging from 2.69 to 4.68. Prior to the naloxone infusion, 
one rat completed only four trials on the morphine lever 
after receiving 17.8 mg/kg pentazocine, yet an EDso of 
6.92 mg/kg was determined in this rat after the naloxone 
infusion. 
A one-way analysis of variance on the potency ratios 
across the different agonists approached statistical signif- 
icance (F,5.26 = 2.27; P = 0.077). The lower efficacy ago- 
nists tended to have greater increases in potency after 
naloxone infusion than did the higher efficacy drugs. Post 
hoc tests indicated that the potency ratios for penta- 
zocine were significantly higher than those for morphine, 
fentanyl, and etorphine (P < 0.05). 
605 
Effects of continuous morphine infusion on the 
discriminative stimulus effects of lz-opioid agonists 
The mean premorphine EDsos for stimulus generaliza- 
tion to morphine, fentanyl, and meperidine, in the groups 
of five to six animals tested with these drugs, were 1.33, 
0.011, and 7.29 mg/kg, respectively. These values are sim- 
ilar to the mean baseline EDsos of these three drugs for 
the whole group of 18 rats (see Fig. 1). 
The stimulus-generalization curves for ~t-opioid ago- 
nists before and after the morphine infusions are shown 
in Fig. 4; EDs0 values and potency ratios are listed in 
Table 2. A 7-day SC infusion of 0.75 mg/kg per h mor- 
phine did not produce significant tolerance to the dis- 
criminative stimulus effects of morphine. Although the 
potency of morphine was decreased in five of the six rats 
tested, it was increased in one rat; the mean potency ratio 
of morphine for the group of six rats was 0.70 (Table 2). 
Continous exposure to morphine appeared to have no 
affect on the discriminative stimulus effects of etorphine. 
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Fig. 4. Stimulus generalization of morphine 
(n = 6), fentanyl (n = 5), meperidine (n = 5), 
etorphine (n = 5), and buprenorphine (n = 5) 
in rats continuously treated with morphine. 
Dose-response curves were generated twice in 
each animal, before (open circles) and after 
(closed circles) a 7-day infusion of 0.75 mg/kg 
per h morphine. The highest dose of fentanyl 
decreased responding in one animal after the 
morphine infusion. Abscissa: cumulative drug 
dose in mg/kg. Ordinates: mean number of tri- 
als terminated by a response on the morphine- 
appropriate choice lever. Each point repre- 
sents the mean of five or six animals. Other 
details as in Fig. 1 
Table 2. Mean EDs0 (mg/kg) with 95 % 
confidence limits (n = 5-6) for the dis- 
criminative stimulus effects of g-opioid 
agonists before and after a 7-day infusion 
of 0.75 mg/kg per h morphine 
Test drug Premorphine Postmorphine Potency P value ° 
EDso EDso ~ ratio b 
Buprenorphine 0.010 0.027 d 0.38 0.141 
(0.007, 0.014) (0,005, 0.152) (0.09, 1.64) 
Etorphine 0.0007 0.0009 0.80 0.656 
(0.0003, 0.0016) (0.0003, 0.0023) (0.23, 2.86) 
Fentanyl 0.011 0.028 0.40 0.005 
(0.006, 0.020) (0.018, 0.044) (0.26, 0.062) 
Meperidine 7.29 12.7 0.57 0.082 
(4.19, 12.7) (6.93, 23.4) (0.29, 1.i2) 
Morphine 1.33 2.37 0.56 0.127 
(1.06, 1.68) (1.30, 4.34) (0.25, 1.26) 
a Determined 24 h after removal of pump 
b Calculated by dividing premorphine ED~ 0 by postmorphine EDso for each subject, then 
determining the group mean 
° For pre- versus postmorphine EDso 
a Includes value estimated for one rat that completed fewer than 10 trails on the drug lever 
(see Methods) 
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infusion of morphine was 0.80 (Table 2); however, there 
was a large degree of individual variability in the re- 
sponses to etorphine. The continuous administration of 
morphine did not  affect the ability of one rat to discrimi- 
nate etorphine (PR -- 1.0); however, two of the rats ex- 
hibited a profound tolerance (PR < 0.3), to the discrimi- 
native stimulus effects of etorphine, whereas the remain- 
ing two rats exhibited a sensitization (PR > 2.0) 
The stimulus-generalization curves for fentanyl, mepe- 
ridine, and buprenorphine, were all shifted to the right 
after the morphine infusions, indicating that cross-toler- 
ance to the interoceptive cues of these drugs did develop. 
The largest decrease in potency was seen in the responses 
to fentanyl. Following the morphine infusion all five of 
the rats tested with fentanyl showed a decreased sensitiv- 
itiy to of fentanyl and, similarly, all five of the rats tested 
with meperidine showed a decreased sensitivity to mepe- 
ridine, although this latter difference only approached 
statistical significance (Table 2). Although the differences 
between the pre-and postmorphine EDs0s for buprenor- 
phine also failed to reach significance, four of the five rats 
tested had decreased sensitivity to buprenorphine. In 
fact, one rat responded on the morphine lever only 6 
times in the postmorphine condition. This inability to 
surmount the morphine-induced tolerance is reflected in 
the large confidence limits of the postmorphine EDso for 
the stimulus generalization to buprenorphine (Table 2). 
Effects of continuous fentanyl infusion on the 
discriminative stimulus effects of l~-opioid agonists 
The mean prefentanyl EDs0s for stimulus generalization 
to morphine (n = 5) fentanyl (n = 5), and meperidine 
(n = 7), for the groups of animals tested with these drugs, 
were 1.55, 0.009, and 9.77 mg/kg, respectively. These val- 
ues are in accordance with the mean baseline EDs0s of 
these three drugs for the whole group of 18 rats (see 
Fig. 1). 
Following infusions of 0.01 mg/kg per h fentanyl, the 
generalization curves for morphine, fentanyl, and mepe- 
ridine were shifted slightly to the right (Fig. 5); however, 
in each case the differences between the pre- and post-fen- 
tanyl EDs0s failed to reach statistical significance (Table 
Table 3. Mean EDso (mg/kg) with 95 % confidence limits (n= 5 7) 
for the discriminative stimulus effects of g-opioid agonists before 
and after a 7-day infusion of 0.01 mg/kg per h fentanyl 
Test drug PrefentanyI Postfentanyl Potency P value ° 
EDso EDso a Ratio b 
Fentanyl 0.009 0.017 0.50 0.085 
(0.005, 0.016) (0.007, 0.044) (0.22, 1.16) 
Meperidine 9.77 t4.1 0.69 0.123 
(6.57, 14.5) (10.2, 19.5) (0.42, 1.14) 
Morphine 1.55 2.07 0.75 0.114 
(1.17, 2.05) (1.25, 3.42) (0.50, 1.12) 
"Determined 24 h after removal of pump 
b Calculated by dividing prefentanyl EDso by postfentanyl EDso for 
each subject, then determining the group mean 
c For pre- versus postfentanyl EDso 
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Fig. 5. Stimulus generalization of morphine (n = 5), fentanyl 
(n = 5), and meperidine (n = 7) in rats continuously treated with 
fentanyl. Dose-response curves were generated twice in each animal, 
before (open circles) and after (closed circles) a 7-day infusion of 
0.01 mg/kg per h fentanyt. Abscissa: cumulative morphine (A), fen- 
tanyl (B), and meperidine (C) dose in mg/kg. Ordinates: mean num- 
ber of trials terminated by a response on the morphine-appropriate 
choice lever. Each point represents the mean of five to seven ani- 
mals. Other details as in Fig. 1 
3). The dose-response curve for the group of rats tested 
with fentanyl shifted to the right the most, as the mean 
EDso for stimulus generalization to fentanyl almost dou- 
bled, from 0.009 mg/kg to 0.017 mg/kg, following the 
continuous exposure to fentanyl. Two of the five animals 
in this group, however, showed no change (PR = 1.0) in 
their responses to fentanyl. Similar individual differences 
were apparent in the groups tested with morphine or 
meperidine. 
Effects of continuous meperidine infusion on the 
discriminative stimulus effects of l~-opioid agonists 
The mean pre-meperidine EDsos for stimulus generaliza- 
tion to morphine, fentanyl, and meperidine, in the groups 
of five animals tested with these drugs, were 1.42, 0.013, 
and 12.3 respectively. These values are similar to the 
mean baseline EDs0s of these three drugs for the whole 
group of 18 rats (see Fig. 1). 
A 7-day infusion of 6.25 mg/kg per h meperidine pro- 
duced tolerance and cross-tolerance to the discriminative 
stimulus effects of meperidine, morphine, and fentanyl 
(Fig. 6; Table 4). As was the case with infusion of mor- 
phine and fentanyl, the infusion of meperidine induced 
the most cross-tolerance to fentanyl, although the poten- 
cy of fentanyl was unchanged in one of five rats. The 
meperidine infusion also decreased the potency of mor- 
phine as a discriminative stimulus in four of five rats, 
giving a mean potency ratio for the group of 0.61. The 
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Fig. 6. Stimulus generalization of morphine, fentanyl, and mepe- 
ridine in rats continuously treated with meperidine. Dose-response 
curves were generated twice in each animal, before (open circles) and 
after (closed circles) a 7-day infusion of 6.25 mg/kg per h meperidine. 
Abscissa: cumulative morphine (A), fentanyl (B), and meperidine (C) 
dose in mg/kg. Ordinates: mean number of trials terminated by a 
response on the morphine-appropriate choice leVer. Each point rep- 
resents the mean of five animals. Other details as in Fig. 1 
Table 4. Mean EDso (mg/kg) with 95 % confidence limits (n = 5) for 
the discriminative stimulus effects of g-opioid agonists before and 
after a 7-day infusion of 6.25 mg/kg per h meperidine 
Test drug Pre- Post- Potency P value ° 
meperidine meperidine ratio b 
EDso EDs0 a 
Fentanyl 0.013 0.033 0.40 0.052 
(0.006, 0.025) (0,019, 0.058) (0.14, 1.00) 
Meperidine 12.3 20.3 0.61 0.046 
(6.12, 24.8) (12,1, 34.0) (0.28, 0.98) 
Morphine 1.42 2.35 0.60 0.076 
(1.01, 2.01) (t.58, 3.49) (0.34, 1.09) 
" Determined 24 h after removal of pump 
b Calculated by dividing premeperidine ED5o by postmeperidine 
EDso for each subject, then determining the group mean 
° For pre- versus postmeperidine EDso 
mean potency ratio for meperidine was similar to that for 
morphine, 0.60. Although the potency of meperidine as a 
discriminative stimulus decreased in all five rats, with 
individual potency ratios ranging from 0.24 to 0.87, vari- 
ability among subjects prevented the group data from 
reaching statistical significance. 
Among the three drugs that were both infused and 
tested for morphine-like discriminative effects, morphine, 
fentanyl, and meperidine, meperidine appeared to in- 
duce/i the most tolerance and cross-tolerance when it was 
infused and fentanyl appeared to undergo the biggest de- 
crease in potency when it was tested. However, a two- 
way analysis of variance failed to reveal a significant dif- 
ference among drugs infused (F2,39 = 0.71; P > 0.1), 
among drugs tested for discriminative effects 
(F2,39 = 2.15; P > 0.1), or a significant interaction be- 
tween infused and tested drugs (/74,39 = 0.02). 
Discussion 
We examined the discriminative stimulus effects of wopi- 
oid agonists before and after 7-day infusions of either 
naloxone or one of three g-opioid agonists, morphine, 
fentanyl, or meperidine. In initial tests of stimulus gener- 
alization, each of the three g-opioid agonists, but not 
PCP, generalized from the morphine cue at some dose. 
This is consistent with results from other studies examin- 
ing the discriminative stimulus effects of opioid drugs in 
rats trained to discriminate between 3.0 mg/kg morphine 
and saline (Shannon and Holtzman 1976; Young et al. 
1992). 
Stimulus control of behavior by morphine was stable; 
neither spontaneous sensitization nor tolerance to the 
discriminative stimulus effects of morphine occurred over 
the approximately 1.5-year period following the initial 
training. This despite week-long infusions of naloxone 
and g-opioid agonists, and associated periods without 
daily training sessions. The mean EDs0s for the discrimi- 
native stimulus effects of morphine, determined for indi- 
vidual groups of five or six rats over the course of the 
experiments, did not vary more than 0.2 mg/kg from the 
mean EDs0 (1.22 mg/kg) calculated for the entire group of 
18 rats at the beginning of the experiments. The mean 
EDsos for generalization to fentanyl and meperidine from 
the morphine cue were similarly consistent across time. 
The stability of the learned behavior in drug discrimina- 
tion paradigms is well documented. Behavioral instabili- 
ty can occur in some animals over the course of an exper- 
iment; however, the behavior of most animals can be 
maintained under the stimulus control of a drug for sev- 
eral months, provided that training sessions are regularly 
completed (Schechter et al. 1989; Pugh et al. 1992). 
It has been reported that a suspension of drug discrim- 
ination training for up to 14 days does not affect the 
stimulus generalization curve for morphine (Sannerud 
and Young 1987). In the present study, a 1-week interrup- 
tion of training and implantation of a sham pump also 
had no effect on the discriminative stimulus effects of 
morphine. On the other hand, a 1-week interruption of 
training accompanied by an infusion of naloxone pro- 
duced 1.5- to 4-fold shifts to the left in the dose-response 
curves of the g-opioid agonists. 
Continuous exposure to natoxone will produce up to 
2-fold increases in the number of g-opioid binding sites in 
the brain (Morris et al. 1988), as well as two-fold increases 
in the potency of morphine in assays of analgesic and 
locomotor  activity (Bardo and Neisewander 1987; Mil- 
lan et al. 1988). The effects of continuous exposure to 
g-opioid antagonists on other g-opioid agonist effects are 
not as well understood. There is one report of an en- 
hancement of the reinforcing effects of morphine as mea- 
sured in a conditioned place preference paradigm (Bardo 
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and Neisewander 1987). In another study, the discrimina- 
tive stimulus effects of fentanyl were examined following 
a 7-day infusion of 6.0 mg/kg per day naltrexone (Ayesta 
et al. 1992). No change in the potency of fentanyl as a 
discriminative stimulus was noted in the fentanyl-trained 
rats. However, in another study that examined the dis- 
criminative stimulus properties of morphine following 
continuous exposure to naltrexone there was a 2-fold in- 
crease in the potency of morphine as a discriminative 
stimulus (Young et al. 1991a). In the latter study, rats had 
received 18 mg/kg per day naltrexone for 8 days. In our 
experiments, the potencies of both morphine and fen- 
tanyl as discriminative stimuli were almost doubled fol- 
lowing a 1-week infusion of naloxone, in agreement with 
the results of Young et al. (1991a). 
The present study represents the first time that the 
discriminative stimulus effects of g-opioid agonists other 
than morphine or fentanyl were examined following a 
period of antagonist administration. Etorphine, mepe- 
ridine, buprenorphine, and pentazocine all exhibited 
some degree of increased potency as discriminative stim- 
uli following the continuous administration of naloxone. 
This is in contrast to the results of a previous study of the 
analgesic potency of g-opioid agonists following an infu- 
sion of naloxone (Paronis and Holtzman 1991). For ex- 
ample, in the current study the stimulus-generalization 
curve for pentazocine was shifted in a parallel fashion 
almost 4-fold to the left following naloxone, whereas an 
equivalent naloxone infusion enhanced the analgesic re- 
sponse only to the highest dose of pentazocine. Similarly, 
although there was no change in the analgesic potency of 
either etorphine or buprenorphine subsequent to nalox- 
one infusions (Paronis and Holtzman 1991), both of these 
drugs exhibited enhanced discriminative stimulus effects 
after the naloxone infusions. Thus, the discriminative 
stimulus effects of g-opioid agonists appear to be more 
readily enhanced by a continuous exposure to naloxone 
than are the analgesic effects of these drugs. 
There were differences among drugs in the magnitude 
of the changes in potency induced by naloxone, as the 
potency ratios spanned a 2-fold range, from 1.58 to 3.58 
(Table 1). Although these differences among drugs only 
approached statistical significance, the potency ratios 
nonetheless appeared to vary with the efficacy of the test 
drugs. That is, drugs with a higher efficacy, for instance 
etorphine, were more resistant to naloxone-induced in- 
creases in potency than were drugs of lower efficacy, such 
as buprenorphine and pentazocine. The large degree of 
individual variability inherent in measuring the discrimi- 
native stimulus effects of drugs (Locke and Holtzman 
1986) might be a factor in the differences that were seen. 
However, the individual variability between rats cannot 
be the sole explanation for the differences seen among 
drugs in these experiments. After the natoxone infusions, 
the potency ratio of pentazocine was greater than 2.6 in 
each one of the rats tested, but only one of the rats tested 
with etorphine had an etorphine potency ratio greater 
than 2.0. 
In contrast to the effects of the naloxone infusions, the 
continuous administration of the g-opioid agonists gen- 
erally produced rightward shifts in the stimulus-general- 
ization curves of the drugs tested. In accordance with 
results from other investigators (Emmett-Oglesby et al. 
1988; Young et al. 1991b), rats that received 7-day infu- 
sions of morphine were tolerant to morphine, fentanyl, 
meperidine, and buprenorphine. However, in contrast to 
the results of Young and colleagues, we saw no tolerance 
to the discriminative stimulus effects of etorphine. 
The discrepancies between our results and those of 
other investigators may be due to the different durations 
of the morphine treatment. There is evidence that the 
magnitude of morphine tolerance is related to the dura- 
tion of the chronic administration of morphine (Young et 
al. 1991c). The rats used in the studies of Young et al. 
(1991c) received 15 mg/kg per day morphine for 2 weeks, 
whereas the rats in the current experiments were exposed 
to a roughly equivalent dose of morphine for only 1 week. 
Therefore, it is not surprising that less g-opioid tolerance 
was apparent in the present studies. 
Although infusions of fentanyl also lessened the dis- 
criminative stimulus effects of fentanyl, morphine, and 
meperidine, in each case this effect failed to reach levels of 
statistical significance. These results are in accordance 
with those of other studies of the stimulus generalization 
of fentanyl and morphine to a fentanyl cue after a 1-week 
exposure to either morphine or fentanyl. Tolerance to the 
discriminative stimulus effects of both morphine and fen- 
tanyl were seen after 7 days of twice daily injections of 
8 mg/kg morphine, yet no tolerance was evident follow- 
ing twice daily injections of 0.08 mg/kg fentanyl, a cumu- 
lative dose equal to four times the training dose of fen- 
tanyl (Emmett-Oglesby et al. t988). Tolerance to the dis- 
criminative stimulus effects of morphine and fentanyl 
were seen only when the daily dose of fentanyl was 
tripled, to four injections of 0.12 mg/kg fentanyl. 
When a higher dose of fentanyl, 0.48 mg/kg per day, 
twice the dose used in the present experiments, was in- 
fused via osmotic pumps (Emmett-Oglesby et al. 1989), 
no tolerance to the discriminative stimulus effects of fen- 
tanyl was seen 24 h after terminating the infusion. How- 
ever, 50% of the animals did demonstrate tolerance when 
tested 12 h after the fentanyl treatment was halted. Fen- 
tanyl has a shorter duration of action than morphine and 
meperidine, although its biological half-life, 1-2 h, is sim- 
ilar to that of meperidine (Dahlstr6m et al. 1979; Hug 
and Murphy 1981). It is possible that in the present ex- 
periment the animals that received infusions of fentanyl 
were transiently tolerant to the discriminative stimulus 
effects of g-opioid agonists, but had recovered from this 
tolerance sooner than 24 h following the removal of the 
osmotic pumps. However, if the development of g-opioid 
tolerance involves an alteration at the level of the recep- 
tor, than the duration of action of the drug used to induce 
the tolerance should be relatively inconsequential, pro- 
vided the drug is continuously administered. Indeed, du- 
ration of opioid tolerance will vary with the length of the 
continuous opioid treatment, and recovery from this tol- 
erance is gradual, lasting from days (Young et al. 1990, 
1991b) to weeks (Craft et al. 1989). A more likely explana- 
tion for the lack of tolerance following infusions of fen- 
tanyl is that too few receptors were down-regulated by 
the 0.01 mg/kg per h dose of fentanyl. Hence, although a 
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relatively large dose of fentanyl was infused (7/8 EDs0 for 
generalization per h), apparently this was insufficient to 
occupy and consequently inactivate enough receptors to 
produce tolerance in all animals to the subsequent dis- 
criminative stimulus effects of morphine, meperidine, or 
fentanyl. Among the three ~t-opioid agonists, infusions of 
fentanyl also induced the least tolerance and cross-toler- 
ance to analgesic effects (Paronis and Holtzman 1992). 
The tolerance and cross-tolerance to meperidine, mor- 
phine, and fentanyl seen following 7-day infusions of 
meperidine can then be explained by the relatively lower 
efficacy of meperidine, and the consequently higher frac- 
tional receptor occupation by meperidine. The dose of 
meperidine that was infused, 6.25 mg/kg per h, was rela- 
tively lower than the dose of fentanyl. That  is, meperidine 
was infused at a rate of 1/2 EDs0/h, whereas fentanyl was 
delivered at a rate of 7/8 EDso/h. Therefore, the mepe- 
ridine dose should have activated fewer receptors than 
did fentanyl, and yet the meperidine infusions shifted the 
dose-effect curves of the test drugs further to the right 
than did the fentanyl infusions. As a drug with a lower 
intrinsic activity than fentanyl (Adams et al. 1990), mepe- 
ridine must occupy more receptors to produce the same 
effect as fentanyl. Whether a dose of 1/2 the EDs0 of 
meperidine occupied more receptors than did a dose of 
7/8 of the ED50 of fentanyl is not known. Nonetheless, 
that meperidine induced tolerance whereas fentanyl did 
not, suggests that more receptors were occupied by 
meperidine, and that receptor occupation, not merely ac- 
tivation, is important  in the degree of tolerance produced 
by g-opioid agonists. 
Repeatedly inducing tolerance/sensitization to ~t-opi- 
oid agonists in the same animals may have produced a 
confound that makes interpretation of our results diffi- 
cult. These repeated exposures to the continuous drug 
treatments may have exceeded the plasticity of the opioid 
systems in these animals. In particular, this might explain 
the large degree of individual variability seen following 
similar drug treatments. However, when the data from 
the individual animals are examined, there does not ap- 
pear to be an effect of time on the magnitude of the 
changes in response following the drug infusions. Like- 
wise, there were not any systematic alterations over time 
in the baseline stimulus generalization curves of mor- 
phine, meperidine, or fentanyl. Furthermore, the repeated 
induction of tolerance in rats trained to discriminate 
drugs is not unprecedented (Miksic and Lal 1977; Young 
et al. 1991c; Pugh et al. 1992). Therefore, although repeat- 
ed induction of sensitization and tolerance to g-opioid 
agonists may indeed have had some effect on the magni- 
tude of the changes following the continuous drug treat- 
ments, there were no indications that the results of the 
experiments were unduly affected by the various treat- 
ments. Perhaps exposing the animals to the drug infu- 
sions in a random sequence helped prevent time-depen- 
dent changes in sensitivity to the various drugs that were 
tested. 
In summary, all of the g-opioid agonists tested 
demonstrated enhanced discriminative stimulus effects 
subsequent to infusions of the opioid antagonist nalox- 
one. This consistent increase in potency is in contrast to 
the differential effects of g-opioid agonist infusions on the 
stimulus generalization to morphine, fentanyl, and mepe- 
ridine. The large amount  of variability in the responses of 
the animals to the continuous drug treatments precludes 
forming broad based conclusions; nonetheless, it appears 
that meperidine infusions produced the most tolerance, 
and fentanyl the least tolerance, to ~t-opioid agonists. The 
consistent increases in agonist potency following the 
naloxone infusion and the lack of such consistency fol- 
lowing any of the g-opioid agonist infusions suggests that 
antagonist-induced increases and agonist-induced de- 
creases in the potency of g-opioid agonists are two dis- 
tinct phenomena rather than the reciprocal outcomes of 
a single mechanism of action. 
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